Cargando…

Safe Concurrent Use of Anti-tuberculosis Drugs and Pembrolizumab in a Patient with Non-small-cell Lung Cancer Who Was Infected with Mycobacterium tuberculosis

A 68-year-old Japanese man was diagnosed with lung adenocarcinoma stage IVB. We introduced a first-line chemotherapy of four cycles of carboplatin and pemetrexed and pembrolizumab, followed by pemetrexed and pembrolizumab maintenance therapy. Approximately four months after anticancer therapy, a sma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakahama, Kenji, Kaneda, Hiroyasu, Ogawa, Koichi, Matsumoto, Yoshiya, Tani, Yoko, Suzumura, Tomohiro, Mitsuoka, Shigeki, Watanabe, Tetsuya, Asai, Kazuhisa, Kawaguchi, Tomoya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038460/ https://www.ncbi.nlm.nih.gov/pubmed/35370247 http://dx.doi.org/10.2169/internalmedicine.6811-20

Ejemplares similares

Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian)
por: Izumi, Motohiro, et al.
Publicado: (2020)

Mutational landscape of multiple primary lung cancers and its correlation with non-intrinsic risk factors
por: Izumi, Motohiro, et al.
Publicado: (2021)

Association of thyroid transcription factor‐1 with the efficacy of immune‐checkpoint inhibitors in patients with advanced lung adenocarcinoma
por: Nakahama, Kenji, et al.
Publicado: (2022)

SP142 evaluation contributes to the prediction of immune checkpoint inhibitor efficacy in non-small cell lung cancer with high PD-L1 expression assessed by 22C3
por: Nakahama, Kenji, et al.
Publicado: (2022)

Tumor microenvironment disparity in multiple primary lung cancers: Impact of non-intrinsic factors, histological subtypes, and genetic aberrations
por: Izumi, Motohiro, et al.
Publicado: (2021)

Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor‐tyrosine kinase inhibitors in patients with EGFR‐mutant non‐small cell lung cancer
por: Matsumoto, Yoshiya, et al.
Publicado: (2019)

Vascular endothelial growth factor receptor 2 expression and immunotherapy efficacy in non–small cell lung cancer
por: Nakahama, Kenji, et al.
Publicado: (2022)

Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer
por: Matsumoto, Yoshiya, et al.
Publicado: (2017)

Safety profile and risk factors for bleeding in transbronchial cryobiopsy using a two-scope technique for peripheral pulmonary lesions
por: Nakai, Toshiyuki, et al.
Publicado: (2022)

Concurrent COVID-19 and Tuberculosis in an Immigrant Worker Presenting with Hemoptysis
por: Sahara, Toshinori, et al.
Publicado: (2021)

Readministration of Pembrolizumab after Treatment of Tuberculosis Activated by Initial Pembrolizumab Therapy
por: Murakami, Shuji, et al.
Publicado: (2020)

Concurrent Tuberculosis and Influenza, South Korea
por: Noh, Ji Yun, et al.
Publicado: (2013)

Concurrence of Tuberculosis and Other Major Diseases
por: Tan, Shouyong, et al.
Publicado: (2016)

Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment
por: Anderson, Erik S., et al.
Publicado: (2017)

A Case of Tuberculosis-related Cerebral Venous Sinus Thrombosis and Pulmonary Thromboembolism Successfully Treated with Edoxaban
por: Nishino, Koichi, et al.
Publicado: (2022)

Tuberculosis infection among homeless persons and caregivers in a high-tuberculosis-prevalence area in Japan: a cross-sectional study
por: Tabuchi, Takahiro, et al.
Publicado: (2011)

Can smoking duration alone replace pack-years to predict the risk of smoking-related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan
por: Ogawa, Koichi, et al.
Publicado: (2020)

Carcinomatous pleuritis and pericarditis accompanied by pulmonary tuberculosis
por: Hara, Munechika, et al.
Publicado: (2016)

Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosis
por: Ye, Mei-Feng, et al.
Publicado: (2020)

THU539 Pembrolizumab-induced Hypophysitis Occurring Concurrently With Takotsubo Cardiomyopathy
por: Nadeem, Ifrah, et al.
Publicado: (2023)

Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study
por: Oka, Takako, et al.
Publicado: (2014)

On the Clinical and Bacteriological Aspect of Mixed or Concurrent Infection in Pulmonary Tuberculosis
por: Elsner, Henry L.
Publicado: (1894)

The Successful Treatment of Pulmonary Pleomorphic Carcinoma with Pembrolizumab: A Case Report
por: Matsumoto, Yoko, et al.
Publicado: (2017)

Effects of Gender and Age on Development of Concurrent Extrapulmonary Tuberculosis in Patients with Pulmonary Tuberculosis: A Population Based Study
por: Lin, Chun-Yu, et al.
Publicado: (2013)

Association of combustible cigarettes and heated tobacco products use with SARS-CoV-2 infection and severe COVID-19 in Japan: a JASTIS 2022 cross-sectional study
por: Nishimura, Misako, et al.
Publicado: (2023)

A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC
por: Lemmon, Christopher A., et al.
Publicado: (2022)

Plasma RANTES, IL-10, and IL-8 levels in non–small-cell lung cancer patients treated with EGFR-TKIs
por: Umekawa, Kanako, et al.
Publicado: (2013)

Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer
por: Suzumura, Tomohiro, et al.
Publicado: (2012)

Central nervous system tuberculoma with miliary tuberculosis in the elderly
por: Tetsuka, Syuichi, et al.
Publicado: (2020)

Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis
por: Yang, Yong, et al.
Publicado: (2021)

Correction: Effects of Gender and Age on Development of Concurrent Extrapulmonary Tuberculosis in Patients with Pulmonary Tuberculosis: A Population Based Study
por: Lin, Chun-Yu, et al.
Publicado: (2013)

Concurrent pulmonary zygomycosis and Mycobacterium tuberculosis infection: a case report
por: Patel, Tejal, et al.
Publicado: (2007)

THE ENHANCING EFFECT OF CONCURRENT INFECTION WITH PNEUMOTROPIC VIRUSES ON PULMONARY TUBERCULOSIS IN MICE
por: Volkert, Mogens, et al.
Publicado: (1947)

Concurrent renal tuberculosis and renal cell carcinoma: A coincidental finding
por: Mani, N. S., et al.
Publicado: (2013)

Concurrent atypical diffused tuberculosis and macrorhabdosis in a canary (Serinus canaria)
por: Madani, Seyed Ahmad, et al.
Publicado: (2015)

Concurrent ascending colon adenocarcinoma and ileocecal tuberculosis: A case report
por: Park, Sun Min, et al.
Publicado: (2022)

The prevalence of concurrent pulmonary and extrapulmonary tuberculosis in Uganda: a retrospective study
por: Kyagulanyi, Eddy, et al.
Publicado: (2022)

Two case reports of continued progression of chronic ocular graft-versus-host disease without concurrent systemic comorbidities treated by amniotic membrane transplantation
por: Ikarashi, Hideto, et al.
Publicado: (2021)

A Case of Disseminated Cryptococcal Infection and Concurrent Lung Tuberculosis in a Patient under Steroid Therapy for Interstitial Pneumonia
por: Kuroda, Aoi, et al.
Publicado: (2015)

Pembrolizumab-Induced Immune-Mediated Colitis in a Patient with Concurrent Clostridium Difficile Infection
por: Zhou, Cheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3sqm2t3d7gdh1lmonqse39iv4f